RecruitingNot ApplicableNCT05711446

Double Voiding and Post-transplant UTI

A Randomized Trial of Double Voiding Versus Usual Voiding to Reduce the Incidence of Urinary Tract Infections in Kidney Transplant Recipients


Sponsor

Weill Medical College of Cornell University

Enrollment

438 participants

Start Date

Apr 7, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Urinary tract infections (UTI) are common in kidney transplant recipients and are an important cause of illness and hospital admissions. Past studies have shown that about 1 out of 5 of newly transplanted patients develop UTI within their first 3 months of transplantation. Such UTIs increase the risk for blood stream infection and acute rejection of the kidney, Improvements in urinary voiding techniques may reduce the frequency of UTI. The purpose of this study is to evaluate the benefits of "double voiding" in kidney transplant recipients.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • All adult kidney transplant recipients who undergo routine follow-up at the New York Presbyterian - Weill Cornell Medicine (NYP-WCM) Transplant Clinic.

Exclusion Criteria1

  • Kidney transplant recipients who are discharged after a transplant with an indwelling catheter (Foley)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERDouble Voiding

Participant will be instructed to void twice.

OTHERRegular Voiding

Participant will void as usual


Locations(1)

Weill Cornell Medical College / NY Presbyterian

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05711446


Related Trials